Synaptics Incorporated logo SYNA - Synaptics Incorporated

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 21
HOLD 12
SELL 0
STRONG
SELL
0
| PRICE TARGET: $134.13 DETAILS
HIGH: $170.00
LOW: $105.00
MEDIAN: $130.00
CONSENSUS: $134.13
UPSIDE: 41.07%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Cyclical & Capital-Intensive 80% confidence

Primary model: Normalized Earnings × Cycle Multiple

Valuation Signal Overvalued Strong
Trading 220.9% above fair value
Current Price $95.08
Bear Case $22.22 76.6% downside ($22.22 - $95.08) / $95.08 = -76.6% $1.85 × 12x
Fair Value $29.63 68.8% downside ($29.63 - $95.08) / $95.08 = -68.8% $1.85 × 16x
Bull Case $37.04 61.0% downside ($37.04 - $95.08) / $95.08 = -61.0% $1.85 × 20x

Adjust Assumptions

16.0x
1.85$

Key Value Driver

Through-cycle normalized EPS ($1.85)

Implied Market Multiple 51.3x

Plain-Language Summary

Using 7-year normalized EPS of $1.85 at a 16x cycle multiple, the base-case value is $29.63 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (34 analysts) $134.13
Analyst Range $105.00 – $170.00
Divergence from AlphaVal 78%

Warnings

This company has a built-in lending arm whose debt is mixed in with the main business. We capped the debt adjustment to avoid overstating what the core business owes.
Wall Street's average price target is $134.13 (from 34 analysts). Our estimate is 78% below the consensus -- consider that gap carefully.

Key Risks

  • Standard 10-year DCF produces unreliable terminal values for cyclicals
  • 'Cheap' P/E at cycle peak is the most common value trap — normalize first
  • Captive finance subsidiaries have different risk profiles from manufacturing